Abstract
As part of an ongoing program to develop potential therapeutic agents for the treatment of the neurodegenerative disease Friedreich׳s ataxia (FRDA), we have prepared a number of lipophilic methylene blue analogues. Some of these compounds significantly increase mitochondrial biogenesis and frataxin levels in cultured Friedreich's ataxia cells [1]. This data article describes the chemical synthesis and full physicochemical characterization of the new analogues.
Original language | English (US) |
---|---|
Pages (from-to) | 1105-1114 |
Number of pages | 10 |
Journal | Data in Brief |
Volume | 20 |
DOIs | |
State | Published - Oct 2018 |
ASJC Scopus subject areas
- General